Drug Treatment as HIV Prevention: A Research Update
- 1 December 2010
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 55 (upplement ), S32-S36
- https://doi.org/10.1097/qai.0b013e3181f9c10b
Abstract
Drug use continues to be a major factor fueling the global epidemic of HIV infection. This article reviews the current literature on the ability of drug treatment programs to reduce HIV transmission among injection and noninjection drug users. Most data come from research on the treatment of opiate dependence and provide strong evidence on the effectiveness of medication-assisted treatment for reducing the frequency of drug use, risk behaviors, and HIV infections. This has been a consistent finding since the epidemic began among diverse populations and cultural settings. Use of medications other than methadone (such as buprenorphine/naloxone and naltrexone) has increased in recent years with promising data on their effectiveness as HIV prevention and as new treatment options for communities heavily affected by opiate use and HIV infection. However, few treatment interventions for stimulant abuse and dependence have shown efficacy in reducing HIV risk. The cumulative literature provides strong support of drug treatment programs for improving access and adherence to antiretroviral treatment. Drug users in substance abuse treatment are significantly more likely to achieve sustained viral suppression, making viral transmission less likely. Although there are challenges to implementing drug treatment programs for maximum impact, the scientific literature leaves no doubt about the effectiveness of drug treatment as an HIV prevention strategy.Keywords
This publication has 80 references indexed in Scilit:
- Addressing Research Priorities for Prevention of HIV Infection in the United StatesClinical Infectious Diseases, 2010
- Motivational and skills training HIV/sexually transmitted infection sexual risk reduction groups for menJournal of Substance Abuse Treatment, 2009
- HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug useAIDS Care, 2009
- Effect of incentives for medication adherence on health care use and costs in methadone patients with HIVDrug and Alcohol Dependence, 2009
- Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical modelThe Lancet, 2009
- Substance Use and High Risk Sexual Behaviors among Women in Psychosocial Outpatient and Methadone Maintenance Treatment ProgramsThe American Journal of Drug and Alcohol Abuse, 2009
- Effectiveness of HIV/STD Sexual Risk Reduction Groups for Women in Substance Abuse Treatment Programs: Results of NIDA Clinical Trials Network TrialJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviorsJournal of Substance Abuse Treatment, 2008
- Community Characteristics Associated with HIV Risk among Injection Drug Users in the San Francisco Bay Area: A Multilevel AnalysisJournal of Urban Health, 2007
- Voucher reinforcement improves medication adherence in HIV-positive methadone patients: A randomized trialDrug and Alcohol Dependence, 2007